Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii.
about
Efflux-mediated drug resistance in bacteria: an updateAntimicrobial resistance in Acinetobacter baumannii: From bench to bedsideStructural basis for a new tetracycline resistance mechanism relying on the TetX monooxygenaseThe Novel Aminomethylcycline Omadacycline Has High Specificity for the Primary Tetracycline-Binding Site on the Bacterial RibosomeBad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of AmericaBiology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment OptionsEvolution of Drug-resistant Acinetobacter baumannii After DCD Renal Transplantation.Role of the BaeSR two-component system in the regulation of Acinetobacter baumannii adeAB genes and its correlation with tigecycline susceptibility.Antibiotics and bacterial resistance in the 21st century.Thai ethnomedicinal plants as resistant modifying agents for combating Acinetobacter baumannii infectionsOverexpression of the adeB gene in clinical isolates of tigecycline-nonsusceptible Acinetobacter baumannii without insertion mutations in adeRSCorrelation of ciprofloxacin resistance with the AdeABC efflux system in Acinetobacter baumannii clinical isolates.A truncated AdeS kinase protein generated by ISAba1 insertion correlates with tigecycline resistance in Acinetobacter baumannii.Identification of Acinetobacter baumannii serum-associated antibiotic efflux pump inhibitors.Drug treatment for multidrug-resistant Acinetobacter baumannii infections.Acinetobacter baumannii: emergence of a successful pathogenSmall-molecule inhibition of bacterial two-component systems to combat antibiotic resistance and virulence.Horizontal gene exchange in environmental microbiotaThe challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Acinetobacter baumannii Genes Required for Bacterial Survival during Bloodstream Infection.Serine/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in Staphylococcus aureusClinical and economic impact of common multidrug-resistant gram-negative bacilliIn vitro activity of tigecycline and comparators against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in ItalyCorrelation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York CityAnalysis of tigecycline resistance development in clinical Acinetobacter baumannii isolates through a combined genomic and transcriptomic approach.Current concepts in antibiotic-resistant gram-negative bacteria.RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations.Acinetobacter baumannii: an emerging multidrug-resistant threat.In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.Tigecycline: a critical update.Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii.Establishing the role of tigecycline in an era of antimicrobial resistance.Isolation and Characterization of Acinetobacter baumannii Recovered from Campylobacter Selective Medium.Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates of Acinetobacter baumannii from a Chinese university hospital.Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii.Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.Treatment options for multidrug-resistant nonfermenters.Towards the complete proteinaceous regulome of Acinetobacter baumannii.Efflux-mediated antibiotic resistance in Acinetobacter spp.Genetic Mechanisms of Antimicrobial Resistance of Acinetobacter baumannii.
P2860
Q24609407-F4CD7F09-F11A-4158-A312-82612A82348CQ27024893-B2104E33-045E-4AF9-A867-2368158E0D2EQ27666972-632F6CE9-5A89-4A52-9A67-5433788C828FQ28818623-16F15654-866E-415E-8DB6-0D16BDA27CB9Q29616084-514D207F-D0B1-4B01-A1AE-F54331062F38Q30235064-43C03C18-12DA-4BBD-86AB-3D15F4AD3514Q33694583-36ED401A-6F53-4EE5-B25A-D62DCDBB3AF5Q33914214-6DF39D9A-0416-435C-BFD0-E0435C10EF30Q34156349-5E3514B1-3BCF-4E4F-9B64-394D00737316Q34248092-B90A7CCD-1631-40CE-ABF5-20D4855BC962Q34289989-05277968-64DB-4E8E-B4DC-1BE1CE3EDEA9Q34431949-238B5F9B-FC41-4D46-8A12-EA75CEC1362DQ34482468-3BF79100-380E-439F-B6DD-76DD18E1182FQ34596864-3BD23956-F514-4A84-BE78-FC276F9F81B4Q34601684-3ED4AEE9-67E1-44FD-B677-B393E39B3A91Q34795807-8481B856-C1FB-4889-8788-4D8F8B670B67Q34823364-113FA18A-7F54-480A-85C8-5DD0DAA735D5Q35132724-D673FA1E-7695-445B-B542-71B362C46517Q35482558-DCB24FA0-4C80-4947-8AFB-5CF7E1B5F0CBQ36052630-8F72C942-4663-473B-BDF4-AC2857A96269Q36153912-22E5DD45-ED0B-4809-A4B4-F27A0959CA84Q36482801-35480EEB-4EEE-460D-B536-A290C3CCCC0DQ36509591-E413C472-B812-4D26-81FA-7BBB9B5552B5Q36870951-2D86EF4B-1634-4B7B-BCC5-FCE30E3E343BQ36949625-72487053-B596-4BB1-A988-49FA1FBBCBC3Q36960068-B3755D31-CA1D-484D-B09C-9B7F130AE0A7Q36969955-30BF48B2-E844-4075-ABC4-1950D06F9346Q37202840-59476123-40BA-450D-9C86-5CA6C2655C64Q37220041-0E18BE75-BABB-4E95-BE64-9025043CA7B2Q37233932-D9BE3240-492E-4620-B3AA-5CFA8FA5DB60Q37263566-90328A59-0380-4E98-9CD8-B419EFABE0F1Q37291328-DCB76FCE-B03E-4B27-9711-E1CF7A3CD156Q37421156-AB071D0A-E31D-42D5-AAE8-073B6576C78FQ37544374-70F14434-28E2-40B9-9FE0-62E83F777CCEQ37600495-12D07861-C37B-4A31-87BD-D119479D55CEQ37656243-50ED1328-DA1D-4745-BE17-5435CE0F0027Q37700555-4E805B81-AA19-48F8-8BBE-2705C1600760Q37739723-741A76D7-39D7-4250-AFE3-D683C1AF1D3CQ37822596-7403AAB6-25A4-40CB-B200-D836231AB955Q37838117-1987CF29-72E9-44F3-BC93-84AF44986664
P2860
Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii.
@en
Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii.
@nl
type
label
Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii.
@en
Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii.
@nl
prefLabel
Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii.
@en
Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii.
@nl
P2860
P356
P1476
Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii.
@en
P2093
Jennifer Adams
P2860
P304
P356
10.1128/AAC.01198-06
P407
P577
2007-04-09T00:00:00Z